MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/cncy.70121

Медицинская библиотека · Cancer cytopathology · 2026

Successful simplified genomic profiling of cytology specimens using Aspyre Clinical Test for Lung (Tissue).

Gentile Caren, Herlihy Sarah E, Shapiro Elyse, Evans Ryan Thomas, Green Amanda Shull, King Candace, Rossi Mary Beth, Gillon-Zhang Elizabeth, Schaffernoth James, Knudsen Katherine Elizabeth, Kiser Cory, Yuen Tatiana, Silva Ana-Luisa, Gray Eleanor Ruth, Balmforth Barnaby William, Levin Wendy Jo, Gregg Jeffrey, Van Deerlin Vivianna

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Testing patients with non-small cell lung cancer for actionable variants is essential for guiding treatment decisions in accordance with established cancer care guidelines, though limited quantity and quality of tumor tissue often leaves insufficient material for comprehensive testing. Cytopathology specimens obtained through minimally invasive techniques are a potential source of diagnostic material for genomic profiling, though typically challenging to analyze.

METHODS

A total of 85 DNA or total nucleic acid non-small cell lung cancer samples derived from 45 fine-needle aspirate rinse or pleural fluid samples from the Hospital of the University of Pennsylvania archive were tested using the Aspyre Clinical Test for Lung (Tissue) in Biofidelity's CAP/CLIA laboratory. All samples were previously characterized by the Oncomine Precision Assay Genexus assay (the orthogonal reference method).

RESULTS

Eighty-four of 85 passed Aspyre Lung quality control, one failed. Twenty-six samples were positive for variants in the Aspyre Lung panel: 17 for single nucleotide variants (KRAS, EGFR), three for EGFR insertions/deletions, two for MET exon 14 skipping, and five for gene fusions. Eighty-two of 85 samples were run at standard input levels; three of 85 were run at low input but passed Aspyre Lung controls and include one EGFR exon 20 insertion variant-positive. All results were concordant between methods. Positive Percent Agreement and Negative Percent Agreement were 100%.

CONCLUSIONS

Aspyre Clinical Test for Lung performs effectively on samples derived from fine needle aspirate rinses and pleural fluid. Using these cytology-based specimens for biomarker testing enables pathologists to perform simplified genomic profiling while preserving valuable tissue specimens, potentially reducing the need for additional invasive procedures.

Для цитирования: Gentile Caren, Herlihy Sarah E, Shapiro Elyse, Evans Ryan Thomas, Green Amanda Shull, King Candace, Rossi Mary Beth, Gillon-Zhang Elizabeth, Schaffernoth James, Knudsen Katherine Elizabeth, Kiser Cory, Yuen Tatiana, Silva Ana-Luisa, Gray Eleanor Ruth, Balmforth Barnaby William, Levin Wendy Jo, Gregg Jeffrey, Van Deerlin Vivianna. Successful simplified genomic profiling of cytology specimens using Aspyre Clinical Test for Lung (Tissue).. Cancer cytopathology. 2026. DOI: 10.1002/cncy.70121.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.